Millions of People with Type 2 Diabetes Could Receive Better Treatment Thanks to a New, Simple Low-Cost toolAccording to research announced at the diabetes uk professional conference 2025 and published in The lancet,

Researchers at the university of exeter have developed an innovative way of identifying the most effective glucose-lowering drugs for a person with type 2 diabetes. By Predicting which Drug will lead to the largest reduction in blood glucose levels, the easy-to-use tool would Pave the way for batter health for millions, at the push of a button.

Careful management of blood glucose levels is essential for reduction the risk of serial diabetes complications. However, keeping blood glucose levels in a safe range can be challenging, with only about a third of people with type 2 diabetes meeting targets. With diabetes-Related Complications Devastating Lives and Costing The UK Health Care System £ 6.2 billion every year, there is an urGent need for new appraches to improaches to improve cloud glucose maanagment.

In england alone, more than three million people with type 2 diabetes use glucose-lawering drugs to manage their condition. While metformin is the most common first treatment, Five Other Major Types of Glucose-Lowering Drugs are available. However, their effectiveness varies widely from person to person and it have not been possible to determine the best glucose-launching treatment for each patient-Until now.

The new tool was created to tackle the challenge of which drug to choose after metformin. It was developed and tested using data from one Million People with Type 2 Diabetes in the UK, Linking GP and Hospital Records, with its accuracy verified with data from Clinical Trials.

The research revealed that only 18% of people with type 2 diabetes in the uk have been treated with the most effective glucose-laering drug for them.

Modeling showed that starting people on the drug recommended by the new tool would lead to marked Reductions in Blood Glucose Levels (HBA1C) At One Year, of Around 5MMMOL/MOL ON AVERAGE. Importantly, these improvements in blood glucose levels could approximate

The tool’s use was also predicted to lower risks of developing serial long-term diabetes complications involving Heart Attacks, Strokes and Kidney Disease.

Using routinely collected clinical information, the tool offers a low-price, practical, immediatively usable solution that would transform the treatment of type 2 diabetes. For Millions of People with Type 2 Diabetes, its use would ensure they receive Complications.

The tool’s performance in Clinical Practice is Currently Being Assessed In 22,500 Patients with Type 2 Diabetes Across SCOROSS SCOTland, which will inform its roll-ites the uk and globle New Era of Personalized Treatment for People with Type 2 Diabetes.

John Dennis, Associate Professor at the University of Exteer Who LED the study, said, “We have developed a complete new personalized apps for diabetes treatment for diabetes treatment With Type 2 Diabetes in the UK and Worldwide.

“For the first time, our model allows People Living with Type 2 Diabetes to Quickly Identify The Best Treatment to Manage Their Blood Sugar Levels, Helping Reduce Their Risk of Diabets Complications Major Advance on the current approach to choosing diabetes medicines. “

Professor andrew hattersley from the university of exter, added, “critically, our model can be implemented in clinical care immediatily and at no additional cost. As Sex, Weight and Standard Blood Tests that are performed routinely.

Dr. Elizabeth Robertson, Director of Research and Clinical At Diabetes UK, Said, “This Innovation Using Using Routine Clinical Data Cold Help CountLess People with Type 2 Diabetes to Get their Blod Sugar Levels Into a safe range, significant redeucing their risk of devastating diabetes complications and starting the burden of living with this relativeless condition.

“If shown to be effective in practice and widely adopted by health services in the uk and globally, this tool could mark the most significant advance in type 2 diabetes care in more than a definition, IMPRIVING Outcomes for Millions. “

Dr. Adam Babbs, Head of Translation at the Medical Research Council, which was a funder of the study, said, “This study is a trailblazing example of why we we we we we we we Wee We’Rech Research into Development of Precision Medicine, which ensures that the right patient receives the right therapy at the right time.

“With Large Variation Between Individuals with Type 2 Diabetes in How they Respond to Treatments, And Many Different Treatments Available, Precology like this like Outcomes and provide efficiencies for the health care system. “